Dr. Yurgelun is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
450 Brookline Ave
Boston, MA 02215Phone+1 617-632-6835
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 2009 - 2012- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2006 - 2009
Columbia University Vagelos College of Physicians and SurgeonsClass of 2006
Certifications & Licensure
FL State Medical License 2022 - Present
MA State Medical License 2009 - 2026
ME State Medical License 2023 - 2026
NH State Medical License 2022 - 2026
RI State Medical License 2022 - 2026
VT State Medical License 2022 - 2026
CT State Medical License 2022 - 2025- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Systematic Hereditary Pancreatic Cancer Risk Assessment and Implications for Personalized Therapy Start of enrollment: 2017 Feb 24
Publications & Presentations
PubMed
- Prevalence and Distribution of Unexpected Actionable Germline Pathogenic Variants Identified on Broad-Based Multigene Panel Testing Among Patients With Cancer.Kara K Landry, Michael J DeSarno, Lindsay Kipnis, Farid Barquet Ramos, Katelyn M Breen
JCO Precision Oncology. 2024-12-01 - Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor.Paul E Oberstein, Andressa Dias Costa, Emily A Kawaler, Victoire Cardot-Ruffino, Osama E Rahma
Cancer Immunology Research. 2024-09-03 - 1 citationsClinical outcomes and ctDNA correlates for CAPOX BETR: a phase II trial of capecitabine, oxaliplatin, bevacizumab, trastuzumab in previously untreated advanced HER2+ g...Harshabad Singh, Kristen E Lowder, Kevin Kapner, Ronan J Kelly, Hui Zheng
Nature Communications. 2024-08-09
Journal Articles
- Germline Cancer Susceptibility Gene Variants, Somatic Second Hits, and Survival Outcomes in Patients with Resected Pancreatic CancerRichard F Dunne, Leona A Doyle, William C Hahn, Jason L Hornick, Andrea J Bullock, Sapna Syngal, Albert C Koong, Natalia Khalaf, Brian M Wolpin, Douglas A Rubinson, Da..., Nature
- Validation of a Targeted Next-Generation Sequencing Approach to Detect Mismatch Repair Deficiency in Colorectal AdenocarcinomaLynette M Sholl, Amitabh Srivastava, Neal I Lindeman, Matthew B Yurgelun, Fei Dong, Nature
Lectures
- Implementation of systematic genetic counseling (GC) and multigene germline testing (MGT) for pancreatic cancer (PC) patients (pts).ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/24/2020
- Improving cascade genetic testing for families with inherited pancreatic cancer (PDAC) risk: The GENetic Education, Risk Assessment and TEsting (GENERATE) study.ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/24/2020
- Improving cascade genetic testing for families with inherited pancreatic cancer (PDAC) risk: The genetic education, risk assessment and testing (GENERATE) study.2019 ASCO Annual Meeting - 6/1/2019
- Join now to see all
Press Mentions
Starch Supplement Reduces the Risk of Some Hereditary CancersJuly 26th, 2022- Daily Aspirin Reduced CRC Risk in Lynch Syndrome PatientsJune 19th, 2020
Therapy-Associated Polyposis May Mimic Hereditary CRC Symptoms in AYA Cancer SurvivorsFebruary 20th, 2020- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
